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To study the effects of Mesima Reishi UE-1 on the metastatic phenotype of the human ovarian cancer 
cell line HO8910. HO8910 cells were pretreated with different concentration of Mesima Reishi UE-1 in 
vitro. Using cell proliferation assay, spreading and adhesion assay, cell migration and invasion assay, 
zymography, immunocytochemical staining and RT-PCR, we examined the effects of Mesima Reishi UE-
1 on cell proliferation, motility, adhesion and expression of MMP-2, 9 in vitro. Mesima Reishi UE-1 
directly inhibited HO8910 cell proliferation in vitro. And pretreated with different concentrations of 
Mesima Reishi UE-1, HO8910 cells motility, adhesion and invasion were inhibited significantly. The 
activity of MMP-9 was inhibited in a dose-dependent manner. The protein and mRNA expression of 
MMP-2, 9 were also inhibited. Mesima Reishi UE-1 suppresses invasion of human ovarian cancer cells 
in vitro. 
 






Human ovarian cancer, which occurs mainly in post-
menopausal women, is the leading cause of death from 
gynecological malignancy (http://www.ovariancancer.org/ 
about-ovarian-cancer/statistics/accessed 10/19/09). 
Since ovarian cancer often remains clinically silent, the 
majority of patients with ovarian carcinoma have 
advanced intraperitoneal metastatic disease at diagnosis, 
resulting in a poor prognosis. About 80% of ovarian 
cancer cases are diagnosed at an advanced stage after 
metastasis has occurred (http://www.ovariancancer.org/ 
about-ovarian-cancer/statistics/accessed 10/19/09; 
Roomi et al., 2010). There are more than 200,000 women 
worldwide who die of ovarian cancer every year. 
Developing and exploiting Chinese herbal medicines to 
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agents’ research.  
Mesima Reishi UE-1 is a compound preparation which 
is extracted from Phellinus linteus and Ganoderma 
lucidum and composed of polysaccharides. P. linteus and 
G. lucidum were mixed in equal proportion (1:1) to 
produce Mesima Reishi UE-1. The anti-tumor function of 
P. linteus was first discovered by Japanese scholars 
(Ikekawa et al., 1968). Since the 1970s, a series of 
studies has shown that G. lucidum can suppress the 
growth of transplanted tumors in mice (Li et al., 2008; 
Sanodiya et al., 2009; Weng, 2007). The chemical 
components of G. lucidum are complicated: They involve 
polysaccharides, flavonoids and alkaloids, amino acids, 
steroids, oligosaccharides, proteins, mannitol, etc 
(Zjawiony et al., 2004). Among these components, G. 
lucidum polysaccharide (GLPS) has been identified as 
one of its major bioactive components, showing multiple 
pharmacological effects, such as immunomodulation, 
anti-oxidation, hepatoprotection, anti-proliferation and 





prolong patients’ survival time (Xu et al., 2011; Hu et al., 
(2002). The mechanism is thought to be due to the 
inhibition of vascular endothelial proliferation, as a 
consequence of reduction of vascular endothelial growth 
factor (VEGF) produced by the tumor cells, and the 
induction of tumor cell apoptosis (Shao et al., 2004). The 
polysaccharides were consisted of D-rhamnose, D-
xylose, D-fructose, D-galactose and D-glucose and linked 
together by β-glycosidic linkages (Cao and Lin, 2004). 
The main medicinal components were polysaccharides 
including intracellular polysaccharide (IPS) and 
exopolysaccharide (EPS) (Guo et al., 2009). The 
structure of a portion of water-soluble mycelial poly-
saccharide from P. linteus was a core (1-3)-linked glucan 
heavily substituted via (1-6) links with (1-3) linked 
mannose chains (Baker et al., 2008). During the past few 
decades, it has been found that polysaccharides isolated 
from P. linteus also have antitumor and immune-
modulating activities (Moradali et al., 2007; Zhang et al., 
2007; Li et al., 2004; Kim et al., 2006; D Sliva et al., 
2008).  
Tumor invasion and metastasis are the most important 
characteristics of malignancy, which is the consequence 
of biological behaviors, including enhanced tumor cell 
adhesion, proliferation, and enzymatic degradation of 
matrix (Leber and Efferth, 2009; Coussens and Werb, 
2002; Zhang et al., 2005; Chambers et al., 2002). Matrix 
metalloproteinase (MMP) expression has been shown to 
be linked to tumor invasion in many different tumors 
(Roomi et al., 2010; Hojilla et al., 2003; Deng et al., 2010; 
Strongin, 2006) and matrix metalloproteinases (MMPs) 
play essential roles in the whole process of tumor 
invasion and metastasis (Hojilla et al., 2003; Deng et al., 
2010; Strongin, 2006; Van Hinsbergh and Koolwijk 2008; 
Rundhaug, 2005). Clinical studies have marked the 
association of MMP expression with progression of 
ovarian cancer (Roomi et al., 2010; Lopata et al., 2003; 
Torng, 2004). During this process, MMP-2 and MMP-9 
play a critical role in tumor invasion and metastasis (Li et 
al., 2008; Overall and Kleifeld, 2006; Duffy et al., 2008). 
Patients with metastatic cancers can no longer be cured 
by local therapy alone and usually die after painful 
chemotherapy. Thus, control of cancer metastasis is an 
important issue in tumor treatment (Chia et al., 2010; 
Malemud, 2006). 
In this study, we examined the effect of UE-1 on 
invasion of human ovarian cancer cells by investigating 
the proliferation, adhesion, motility, the activity and 
expression of MMPs. The results show that UE-1 can 








HO8910 cells (human ovarian cancer cell line) were  obtained  from  




the Key Laboratory of Pathobiology, Ministry of Education, Norman 
Bethune College of Medicine. Cells were cultured in high glucose-
Dulbecco modified eagle medium (H-DMEM; Hyclone, USA) 
supplemented with 10% fetal bovine serum (FBS; Hyclone, USA) in 
humidified 5% CO2 atmosphere at 37°C. 
 
 
Drugs and reagents  
 
Mesima Reishi UE-1 was kindly provided by Nikkei Edible Fungus 
Research Institute. The ratio of polysaccharides of G. lucidum is 
45.5 and 38.9% of P. linteus. They were then divided into a high 
dose group (200 mg/l) and a low dose group (100 mg/l) by diluted 
to required concentration with H-DMEM supplemented with 10% 
FBS (Zhang et al., 2010). H-DMEM supplemented with 10% FBS 
was employed as a control. 
G. lucidum was a kind of polysaccharides peptide which the ratio 
of polysaccharides is 45.5%. Polysaccharides ratio of P. linteus was 
38.9%. Mesima Reishi UE-1 was kindly provided by Nikkei Edible 
Fungus Research Institute. They were then divided into a high dose 
group (200 mg/l) and a low dose group (100 mg/l) by diluted to 
required concentration with H-DMEM supplemented with 10% FBS 
(Zhang et al., 2010). H-DMEM supplemented with 10% FBS was 
employed as a control. 
 
 
Cell proliferation assay  
 
HO8910 cells were harvested by trypsinization when grown until 
80% confluence and resuspended in 10% FBS H-DMEM. Cells 
were seeded onto 96-well culture plates at a density of 2 000 cells/ 
well and incubated at 37°C for 24 h. Then cells were washed with 
phosphate- buffered saline (PBS) 3 times and cultured in 10% FBS 
H-DMEM with Mesima Reishi UE-1 at concentration of 0, 100 and 
200 mg/l for 48 h. Serum-free medium was added with 10 µl cell 
counting kit (CCK-8; Sigma, USA) to each well, and incubated at 
37°C for 2 h. A microplate reader (BIO-RAD, Model 550, USA) was 
used to measure absorbance at 450 nm. CCK 8 assay was 
performed in at least three independent experiments with six 




Cell spreading assay  
 
HO8910 cells were cultured for 48 h in 10% FBS H-DMEM 
containing 0, 100 and 200 mg/l Mesima Reishi UE-1 0, 100 and 200 
mg/l, respectively. 96-well culture plates were precoated with 5 
µg/cm
2 
fibronectin (FN; BD Bioscience, USA). Then cells in each 
group were seeded into 6 replicate wells at 1x10
4
 cells/ well and 
incubated at 37°C for 60 min. They were then washed with serum-
free medium. The shape of the cells was photographed under a 
microscope (Olympus, Japan) at 0.5, 3 and 24 h. Cells with round 
shape were defined as not spreading and those with protuberance 
and extension had spread.  
 
 
Cell adhesion assay  
 
96-well culture plates were precoated with Fibronectin as in the cell 
spreading assay. Serum-free medium (50 µl), supplemented with 10 
g/l Bovine serum albumin (BSA), was added to each plate to block 
nonspecific adhesion. HO8910 cells were cultured for 48 h in 10% 
FBS H-DMEM containing Mesima Reishi UE-1 (0, 100 and 200 
mg/l). Then, cells in each group were seeded onto 12 replicate 
wells at 1x10
4 
cells/well and allowed to attach for 2 h at 37°C. The 
cells were washed with PBS 3 times to remove non-bound cells. 
Cell counting reagent (CCK-8; Sigma,  US)  (10 µl)  were  added  to  




each well. After incubation for 60 min at 37°C, absorbance was 
measured at 450 nm. The absorbance value of the washed plates 
was A; the value of unwashed plates was B, the adherence ratio 
A/B×100%. Results are expressed as mean± (SD). 
 
 




 cells were seeded onto a 6-well culture plate and then grown 
until monolayer confluence. A cell wound was produced with a 100 
µl micropipette tip and gently washed with serum-free medium to 
remove the detached cells. Monolayers with cell wounds were 
cultured in 10% FBS H-DMEM containing 0, 100 and 200 mg/l 
Mesima Reishi UE-1. The wound area was observed by microscope 
(Olympus, Japan) with a 100 x magnification at 24, 48, 72 and 96 h.  
 
 
Cell invasion assay (Boyden chamber invasion assays) 
 
NIH3T3 mouse fibroblast cells were cultured until confluence in 
RPMI1640 supplemented with 10% FBS. Then cells were starved 
for 24 h in serum-free medium and the supernatant was collected 
as conditioned medium. Cell invasion assays were performed using 
Boyden chambers with 8 µm pores. Boyden chambers which 
contain polycarbonate membrane were precoated with 60 µl 
Matrigel (1:4 dilution) and incubated at 37°C for 30 min. HO8910 
cells were cultured for 48 h in 10% FBS H-DMEM containing 0, 100 
and 200 mg/l Mesima Reishi UE-1. Cells were harvested and 
resuspended in serum-free medium. 1x10
5
 cells in 100 µl medium 
were seeded into each of the chambers. 400 µl conditioned medium 
was added into the lower chamber to create a chemotactic gradient. 
After 4 h incubation at 37°C, the membranes were fixed with 4% 
paraformaldehyde for 30 min and stained by hematoxylin-eosin 
staining. Ten microscopic fields from the under surface were 
randomly chosen for analysis. Results are expressed as mean 
standard deviation (±SD). 
 
 
Protein expression of MMP-2, 9 (immunocytochemistry)  
 
HO8910 cells were plated onto chamber glass slides and grown 
until 80% confluence. The cells were then cultured in 10% FBS H-
DMEM containing Mesima Reishi UE-1 0, 100 and 200 mg/l for 48 h 
and then fixed with 4% paraformaldehyde for 30 min at room 
temperature. Reaction products were visualized by the SP immune-
histochemistry kit (SP kit; Maixin, China) using diaminobenzidine 
tetrahydrochloride (DAB; Maixin, China) as the developer. Those 
cells which cytoplasm appeared brown granules and color stronger 
than the background were positive. Twenty visual fields were 
chosen on each slide. The gray-scale value (IOD) was analyzed 
with image-Pro plus 6.0. Results are expressed as the mean (±SD). 
 
 
mRNA expression of MMP-2, 9 (reverse transcriptase-
polymerase chain reaction (RT-PCR) analysis) 
 
HO8910 cells were cultured for 48 h in 10% FBS H-DMEM 
containing Mesima Reishi UE-1 0, 100 and 200 mg/l, respectively. 
Cells were harvested by trypsinization. Total RNA was extracted 
from the experimental or control cells by TRIzol (Invitrogen, USA) 
according to the manufacturer's protocol.  
5 µg RNA was transcribed into cDNA by Moloney murine 
leukemia virus (M-MLV) reverse transcriptase and olignucleotide (T) 
18 primer. 1 µl cDNA was added into the PCR system (Takara, 
Dalian, China) for 35 cycles at an annealing temperature of 55°C. 
MMP-2, 9 and β-actin were amplified using the following primer 





AGAGATTCTCACTGGGGC -3' (MMP-2 reverse); 5'- 
TGGCAGAGATGC GTGGAGA -3' (MMP-9 forward), 5'- 
GGCAAGTCTTCCGAGTAGTTTT -3' (MMP-9 reverse); 5'-
TGGAATCCTGTGGCATCCATGAAAC-3' (β-actin forward), 5'-
TAAAACGCAGCTCAGTAACAGTCCG-3' ( β-actin reverse). 
Amplification of β-actin was used to estimate the efficiency of 
cDNA synthesis and equal loading. 5 µg amplified products were 
analyzed by electrophoresis on 1% agarose gel and photographed 
by gel Doc 2000 photography system (Bio-Rad, USA). The β-actin 
of each sample was calculated for the relative expression intensity 
to quantify and analyze the bands density of the products on the 






HO8910 cells were seeded into the 24-well culture plate at a 
concentration of 5 x10
4
 cells/ml and incubated at 37°C for 24 h. 
After removing the medium, we added 10% FBS H-DMEM 
containing Mesima Reishi UE-1 0, 100, 200 mg/l and cells were 
cultured for 48 h. Cells were then cultured in 200 µl serum-free 
medium for 24 h. Supernatant was collected, centrifugated at 2 000 
rpm /min for 5 min to remove cell debris and concentrated by two 
folds volume cold acetone. Protein quantitation was performed 
using Bio-Rad reagent. Gelatin zymography was performed in 10% 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with 1.0 g/l 
gelatin. After electrophoresis, the gel was transferred to 2.5% Triton 
X-100 with gentle agitation for 1h, then incubated in development 
buffer ( 50 mmol/l Tris, 10 mmol/l CaCl2 ,200 mmol/L NaCl, 1 µmol/l 
ZnCl2 , pH7.5 ) at 37°C for 18 to 24 h. The gel was stained with 
Coomassie blue R250 solution for at least 2 h, followed by 
decolorization with the mixture of methyl alcohol and acetic acid. 
The gel was observed by gel Doc 2000 photography system (Bio-






Effects of UE-1 on proliferation of HO8910 cells in 
vitro  
 
HO8910 cells were cultured in 10% FBS H-DMEM 
containing Mesima Reishi UE-1 0, 100 and 200 mg/l for 
48 h. There was a significant (p < 0.01) inhibition of 
HO8910 cell proliferation in vitro (Figure 1). Inhibition 
ratio of the experimental groups= [(OD value of the 
control- OD value of experimental groups)/ OD value of 
the control ×100%] were 48.28 and 55.17%, respectively. 
 
 
Effects of UE-1 on spreading of HO8910 cells in vitro  
 
There was no difference in cell shape between 
the experimental groups and the control at 30 min. By 3 
h, a few of the control cells had spreading features, while 
the experimental groups were still a round shape. The 
experimental groups had no change compared with their 
30 min morphology. The spreading of cells in the control 
was significantly more than that of the two experimental 
groups by 12 h. At 24 h, cells of the control had fully 
spread, while only a few cells of the experimental  groups  



















                                                                *P < 0. 01 versus control  
 
Figure 1. The effect of UE-1 (mg/L) on proliferation of HO8910 cells in vitro (n 










Figure 2. The effect of UE-1 (mg/L) on the spreading of HO8910 cells. 1x104 
cells were seeded into each well of 96 -well plates precoated with fibronectin. 
Cells were washed three times and photographed after incubation for 3 h (upper 
panel), 12 h (middle panel), 24 h (lower panel). Photographed cells were 




had spreading features. There were many dead cells in 
the experimental groups (Figure 2).  
 
 
Effects of UE-1 on adherence behavior of HO8910 
cells in vitro 
 
The adherence assay showed that after 2 h co-culture, 
the cells attached to fibronectin in the experimental 
groups were fewer than in the control. This effect was 




Effects of UE-1 on migration behavior of HO8910 
cells in vitro  
The migration assay (Figure 4) showed that migration 
capability of the experimental groups was limited, while 
the cells of the control group were growing actively, fully 
spread with high migration capability. The motility and 
migration speed of the cells which pretreated with UE-1 
were decreased significantly. By 96 h, the wounds  of  the  































                            
                                                     *P < 0.05 versus control  
 
Figure 3. UE-1 (mg/L) inhibited the adhesion of HO8910 cells in vitro (n = 6, 
±s). Statistical results showed that adherent cells of the experiments groups 









Figure 4. The effect of UE-1 on the motility of HO8910 cells. 
5x10
5
 cells were seeded onto 6-well cell culture plates and 
then cultured to monolayer confluence. A cell wound was 
created with a 100 µl micropipette and photographed at a 




control culture had healed, while those of the experi-
mental groups were still unhealed. Adherence of the 
experimental group cells was decreased and there were 
many floating dead cells. 
 
 
Effects of UE-1 on invasion of HO8910 cells in vitro  
 
After 6 h, cells in all groups had invaded through Matrigel 
in the Boyden chamber assay (Figure 5). The cell number 
of the control which migrated through the gel and invaded 
to the lower surface of the chamber membrane with 
spreading features was considerable. In the experiment  
groups, fewer cells had invaded and few of them were 
spread. All these shows that UE-1 significantly (p < 0.01) 
decreased the invasive ability of the cells when compared 
with the control cells (n = 6, x ±s). 
 
 
Effects of UE-1 on protein expression of MMP-2, 9  
 
We   used   immunocytochemistry   to    examine   protein  



























                                             *P < 0. 01 versus control  
 
Figure 5. The effect of UE-1 (mg/L) on the invasion of HO8910 cells in vitro. 
Results describe the number of cells which had invaded to the lower surface of 
the chamber membrane. Invasive cell number was quantified by counting the 









Figure 6. Effect of UE-1 (mg/L) on the protein expression of MMP-2 (upper panel) and 9 (lower panel) of HO8910 





expression of MMP-2 and MMP-9 in each group. There 
was strong positive expression of MMP-2 and MMP-9 in 
the control cells whereas expression was low in the 
experiment groups’ cells. The control group cells were 
triangular, round or polygonal, had high adherence and 
refraction while the cell number in the experimental 
groups was decreased accompanied by with low 
refraction and particles in the cytoplasm. Inhibition of 
protein expression of MMP-2 and MMP-9 was in a dose-
dependent manner (Figure 6 and Table 1). 
 
 
Effects of UE-1 on mRNA expression of MMP-2, 9  
 
HO8910 cells were cultured for 48 h in 10% FBS H-
DMEM containing Mesima Reishi  UE-1 0,  100  and  200  




Table 1. Effect of UE-1 (mg/L) on the expression of MMP-2 and MMP-9 protein of HO8910 cells. 
 
Group (mg/l) MMP-2 expression (IOD value) MMP-9 expression (IOD value) 
UE-1  0 184.17±652.39 157.80±280.93 
100  129.06±847.21* 109.26±371.98* 
 200  63.98±161.09** 52.12±197.37** 
 
(n= 20, x  ± SD). Twenty visual fields were counted at a magnification of x200. IOD Value refers to gray-scale value 






































Figure 7. (A) Effect of UE-1 (mg/L) on the mRNA expression of MMP-2, 9 of HO8910 cells in 
vitro. Amplification of ß-actin was used to ascertain RNA integrity and equal loading. MMP-2, 
442 bp; MMP-9, 229 bp; β-actin, 362 bp. Lane 1, Marker, DL2000; lane 2, 0 (mg/L the following 
to be same) MMP-9; lane 3, 100 MMP-9; lane 4, 200 MMP-9; lane 5, 0 MMP-2; lane 6, 100 
MMP-2; lane 7, 200 MMP-2; lane 8, 0 β-actin; lane 9, 100β-actin; lane 10, 200 β-actin; (B) 
effect of UE-1 (mg/L) on the mRNA expression of MMP-2 and MMP-9 of HO8910 cells in vitro. 




mg/l. Reverse transcriptase PCR was used to test the 
mRNA expression of MMP-2, 9. The results show a 
significant (p < 0.05) inhibition of mRNA expression of 
MMP-2 and MMP-9 in vitro. The reverse transcriptase-
PCR results were quantified by measuring the optical 
density as described. (Figure 7a, b). The limitation ratio of 
100 mg/l UE-1 on MMP-2 and MMP-9 was 21.6 and 
20.7%, respectively. 
Effects of UE-1 on activity of MMP-9  
 
HO8910 cells were cultured for 48 h in 10% FBS H-
DMEM containing Mesima Reishi UE-1 0, 100 and 200 
mg/l, respectively. Zymography was used to test the 
activity of MMP-9. The result shows that the activity of 
MMP-9 was inhibited significantly in a dose-dependent 
manner. The activity inhibition  ratio of 100  and 200  mg/l  


































Figure 8. (A) Effect of UE-1 (mg/L) on the activity of MMP-9 (92,000 Da, lower panel) of 
HO8910 cells in vitro. Lane1, 0 (mg/L the following to be same) UE-1; lane 2, 100 UE-1; 
lane 3,200 UE-1; (B) effect of UE-1 (mg/L) on the activity of MMP-9 of HO8910 cells in vitro. 









Cancer is a multifactorial disease in which cumulative 
genetic and epigenetic alterations affect multiple distinct 
regulatory circuits within cells. To treat cancer, there is a 
growing belief that combination therapy using multiple 
drugs targeting various cellular pathways would yield 
better outcomes than monotherapies (Chia et al., 2010). 
Tumor invasion and metastasis are the most distinctive 
characteristics of malignant neoplasms and important 
indicators of the tumor patients’ prognosis. These are 
complicated processes, accompanied by extracelluar 
matrix degradation and changes in cell surface receptor 
expression (Leber and Efferth, 2009; Coussens and 
Werb, 2002). In this respect, the Chinese herb Mesima 
Reishi UE-1, which contains various phytochemicals that 
target multiple dysregulated pathways in cancer cells may 
provide a complementary way to treat cancers. Then 
effect on the phenotypic of the ovarian cancer line 
HO8910 were than studied. Our results demonstrate that 
the Mesima Reishi UE-1 not only inhibited the 
proliferation, migration and invasive ability of the cell line, 
but also inhibited the activity and expression of MMP-2 
and MMP-9.  
Inhibiting tumor cell proliferation is the most basic 
means of treating carcinoma in situ and invasive cancer 
(Zhang et al., 2005). Timely control of the proliferation of 
cancer cells has significant meaning for cancer therapy. 
This study demonstrates that low concentrations of UE-1 
inhibited HO8910 cell growth, but that inhibition was out 
of a dose-effect relationship when the concentration 
exceeded a certain range.  
Adhesion   of    cells    is   dependent  on   their  surface  




receptor expression, which also regulate cell shape 
maintenance, cell division and cell movement. Adhesion 
is the initiation step in cancer invasion. The capacity of 
highly invasive tumor cells adhere to extracellular matrix 
components is usually great (Curran and Murray, 2000). 
Consequently, inhibiting the adhesion of tumor cells can 
depress tumor invasion and prevent tumor metastasis 
(Coussens and Werb, 2002). In this study, after 
pretreatment with different concentrations of Mesima 
Reishi UE-1, adhesion and spreading of HO8910 cells 
were inhibited significantly. When the control cells had 
already spread, only a few experimental cells were 
protuberance and extension. There were also a certain 
amount of dead cells. All of these objectives imply that 
EU-1 has the effect of inhibiting cell adhesion. 
Migration is an indispensable step in tumor invasion 
and metastasis. Highly invasive tumor cells typically have 
higher migration capacity (Coussens and Werb, 2002). 
Our study shows that after pretreated with different 
concentrations of Mesima Reishi UE-1, HO8910 cell 
motility was inhibited significantly, and the speed of 
migration was significantly slower than in the control 
group. At 96 h, the wound of the control group had 
healed, while the experimental group’s wound still 
existed. Furthermore, during co-cultivation, the wound of 
the high concentration group was shorted slightly, both 
experimental groups showed inhibited adhesion of cells 
and some cells were floating. All of these observations 
expressly showed that the adhesion and proliferation 
were inhibited. In the cell invasion assay, compared with 
the control group, the experimental group had many 
fewer cells which migrated through Matrigel and the cells 
which had migrate through Matrigel were not fully spread. 
These show that the invasion of HO8910 was 
significantly inhibited by UE-1.  
Matrix metalloproteases play the most essential roles in 
tumor invasion and metastasis. They can help tumor cells 
to invade into blood vessel and the lymphatic system, in 
order to promote tumor proliferation and create a path for 
tumor cell spreading (Chambers et al., 2002; Hojilla et al., 
2003). Thus, knowledge of matrix metalloprotease regu-
lation is of great importance for developing therapeutic 
strategies (Roomi et al., 2010). Matrix metalloprotease 
(MMP) is one of the most important proteases which 
degrade ECM in vivo by degrading extracellular matrix 
and disrupting the basement membrane. A number of 
extracellular factors, including cytokines, growth factors, 
cell contact with ECM and inducers and inhibitors, have 
been implicated in the regulation of MMP expression in 
different types of tumor cells (Roomi et al., 2010; Deng et 
al., 2010; Curran and Murray, 2000; Fortunato and 
Menon, 2002). Consequently, there is evidence that 
MMPs can further promote tumor invasion through tissue 
barriers. During this process, degradation of the 
extracellular matrix and components of the basement 
membrane by proteases, such as matrix metallo-





invasion and metastasis (Li et al., 2008; Overall and 
Kleifeld, 2006; Duffy et al., 2008; Chia et al., 2010). Thus, 
activity of MMPs is one of the most important facts tumor 
invasion and metastasis (Leber and Efferth, 2009; Chen 
et al., 2008). Measuring the effects of tumor cell 
metalloproteinase secretion is an important index for 
assessing the anti-invasive effects of a drug. While at 
least 20 members in the MMP family, mainly secreted by 
tumor cells and mesenchymal cells, MMP-2 and MMP-9 
are the enzyme which has the closest relation to tumor 
invasion process (Bachmeier et al., 2005). In recent 
years, much effort has been taken to develop drugs that 
can inhibit metastasis. However, till now promising 
antimetastatic agents are still lacking (Duffy et al., 2008; 
Chia et al., 2010). In this study, the results show that 
pretreated with different concentrations of Mesima Reishi 
UE-1, the protein and mRNA expression of MMP-2 and 
MMP-9 in HO8910 cells were inhibited significantly. The 
activity of MMP-9 was also inhibited in a dose-dependent 
manner. 
In this study, we have demonstrated that Mesima 
Reishi UE-1 can directly inhibit proliferation, motility, 
adhesion, MMP-2 and MMP-9 activity, protein and mRNA 
expression of HO8910 cells. In addition to this study, it 
has been shown that Mesima Reishi UE-1 can also inhibit 
chick chorioallantoic membrane (CAM) angiogenesis 
(Zhang et al., 2005). To our knowledge, no prior research 
has examined the effects of Mesima Reishi UE-1 on 
human ovarian cancer in vitro. Given the well- evidence 
that of Mesima Reishi UE-1 can suppress human ovarian 
cancer cells invasion in vitro, the results from this study 
lay an experimental foundation for the future development 
of new anti-tumor agents and clinical application of 
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